Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Diseases, Interstitial | 3 | 2026 | 145 | 1.000 |
Why?
|
| Lung Neoplasms | 3 | 2023 | 710 | 0.670 |
Why?
|
| Autophagy | 2 | 2012 | 239 | 0.620 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 4 | 2013 | 162 | 0.560 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2015 | 61 | 0.540 |
Why?
|
| Pulmonary Fibrosis | 2 | 2015 | 81 | 0.450 |
Why?
|
| Early Detection of Cancer | 3 | 2023 | 327 | 0.410 |
Why?
|
| Protein Kinases | 1 | 2015 | 153 | 0.410 |
Why?
|
| Epithelial Cells | 1 | 2015 | 414 | 0.370 |
Why?
|
| Respiratory Tract Diseases | 1 | 2012 | 40 | 0.370 |
Why?
|
| Mitochondria | 1 | 2015 | 413 | 0.330 |
Why?
|
| Bleomycin | 4 | 2015 | 35 | 0.260 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2026 | 1662 | 0.230 |
Why?
|
| Lung | 3 | 2023 | 969 | 0.210 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 707 | 0.210 |
Why?
|
| Hospitalization | 2 | 2021 | 1403 | 0.200 |
Why?
|
| Macrophages, Alveolar | 2 | 2013 | 65 | 0.190 |
Why?
|
| Smoking | 2 | 2026 | 863 | 0.190 |
Why?
|
| Vascular Calcification | 1 | 2021 | 27 | 0.170 |
Why?
|
| Emphysema | 1 | 2020 | 38 | 0.160 |
Why?
|
| Fibroblasts | 2 | 2012 | 423 | 0.160 |
Why?
|
| Tertiary Lymphoid Structures | 1 | 2019 | 5 | 0.150 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2019 | 81 | 0.140 |
Why?
|
| Pneumonia | 1 | 2021 | 295 | 0.140 |
Why?
|
| Cystic Fibrosis | 1 | 2019 | 126 | 0.140 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 326 | 0.130 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 565 | 0.120 |
Why?
|
| Mice | 6 | 2019 | 11172 | 0.120 |
Why?
|
| Humans | 12 | 2026 | 65635 | 0.120 |
Why?
|
| Retrospective Studies | 3 | 2023 | 6948 | 0.120 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2015 | 31 | 0.110 |
Why?
|
| Pulmonary Alveoli | 1 | 2015 | 44 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 129 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 3500 | 0.100 |
Why?
|
| Syndecan-2 | 1 | 2013 | 1 | 0.100 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 237 | 0.100 |
Why?
|
| Cell Death | 1 | 2015 | 289 | 0.100 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2013 | 4 | 0.100 |
Why?
|
| Acute Lung Injury | 1 | 2013 | 45 | 0.090 |
Why?
|
| Sequestosome-1 Protein | 1 | 2012 | 9 | 0.090 |
Why?
|
| Beclin-1 | 1 | 2012 | 22 | 0.090 |
Why?
|
| Respiratory Mucosa | 1 | 2012 | 51 | 0.090 |
Why?
|
| Fibronectins | 1 | 2012 | 44 | 0.090 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2012 | 45 | 0.090 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2012 | 55 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2012 | 116 | 0.090 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 152 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2012 | 132 | 0.090 |
Why?
|
| Animals | 6 | 2019 | 21450 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 181 | 0.090 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2015 | 346 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 156 | 0.080 |
Why?
|
| Cell Lineage | 1 | 2012 | 282 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 401 | 0.080 |
Why?
|
| Cell Line | 1 | 2015 | 2029 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2012 | 215 | 0.080 |
Why?
|
| Risk | 2 | 2021 | 374 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 345 | 0.080 |
Why?
|
| Male | 7 | 2026 | 31285 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 214 | 0.080 |
Why?
|
| Homeostasis | 1 | 2012 | 383 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 441 | 0.080 |
Why?
|
| Sex Factors | 2 | 2026 | 995 | 0.070 |
Why?
|
| Inflammasomes | 1 | 2012 | 352 | 0.070 |
Why?
|
| Age Factors | 2 | 2026 | 1592 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2012 | 718 | 0.060 |
Why?
|
| Models, Biological | 1 | 2012 | 1193 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2012 | 925 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2013 | 3162 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1633 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2021 | 2639 | 0.050 |
Why?
|
| Prevalence | 1 | 2026 | 1453 | 0.040 |
Why?
|
| Disease Progression | 1 | 2026 | 1225 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2019 | 2168 | 0.040 |
Why?
|
| Female | 5 | 2026 | 34298 | 0.040 |
Why?
|
| Aged | 3 | 2021 | 15087 | 0.040 |
Why?
|
| Middle Aged | 3 | 2021 | 18434 | 0.030 |
Why?
|
| Comorbidity | 1 | 2020 | 1120 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 2319 | 0.030 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2015 | 2 | 0.030 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 1 | 2015 | 5 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2015 | 149 | 0.030 |
Why?
|
| Chemokines | 1 | 2015 | 99 | 0.030 |
Why?
|
| Massachusetts | 1 | 2020 | 2154 | 0.030 |
Why?
|
| ROC Curve | 1 | 2015 | 294 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2015 | 185 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 449 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2113 | 0.030 |
Why?
|
| Hydroxyproline | 1 | 2013 | 6 | 0.030 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2013 | 17 | 0.030 |
Why?
|
| Caveolin 1 | 1 | 2013 | 10 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 39 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2013 | 129 | 0.020 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2013 | 7 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 41 | 0.020 |
Why?
|
| Primary Cell Culture | 1 | 2013 | 80 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 491 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 376 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2012 | 142 | 0.020 |
Why?
|
| Caspase 1 | 1 | 2012 | 115 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 498 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 1291 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 797 | 0.020 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2012 | 263 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 1487 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 6349 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 1100 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 3328 | 0.020 |
Why?
|
| Risk Factors | 1 | 2015 | 5466 | 0.010 |
Why?
|